|
|||||
|
|
A Canadian Critical Care Trials Group project in collaboration with the international forum for acute care trialists - Collaborative H1N1 Adjuvant Treatment pilot trial (CHAT): study protocol and design of a randomized controlled trial |
|
| Authors: | Karen EA Burns Clarence Chant Orla Smith Brian Cuthbertson Robert Fowler Deborah J Cook Peter Kruger Steve Webb Jamal Alhashemi Guillermo Dominguez-Cherit Carlos Zala Gordon D Rubenfeld John C Marshall |
| Affiliation: | 1. Discipline of Public Health, The University of Adelaide, Adelaide, South Australia 2. Discipline of Paediatrics, The University of Adelaide, Adelaide, South Australia 3. School of Population Health and Clinical Practice, The University of Adelaide, Adelaide, South Australia |
| Abstract: | BackgroundThe Vaccine Assessment using Linked Data (VALiD) trial compared opt-in and opt-out parental consent for a population-based childhood vaccine safety surveillance program using data linkage. A subsequent telephone interview of all households enrolled in the trial elicited parental intent regarding the return or non-return of reply forms for opt-in and opt-out consent. This paper describes the rationale for the trial and provides an overview of the design and methods.Methods/DesignSingle-centre, single-blind, randomised controlled trial (RCT) stratified by firstborn status. Mothers who gave birth at one tertiary South Australian hospital were randomised at six weeks post-partum to receive an opt-in or opt-out reply form, along with information explaining data linkage. The primary outcome at 10 weeks post-partum was parental participation in each arm, as indicated by the respective return or non-return of a reply form (or via telephone or email response). A subsequent telephone interview at 10 weeks post-partum elicited parental intent regarding the return or non-return of the reply form, and attitudes and knowledge about data linkage, vaccine safety, consent preferences and vaccination practices. Enrolment began in July 2009 and 1,129 households were recruited in a three-month period. Analysis has not yet been undertaken. The participation rate and selection bias for each method of consent will be compared when the data are analysed.DiscussionThe VALiD RCT represents the first trial of opt-in versus opt-out consent for a data linkage study that assesses consent preferences and intent compared with actual opting in or opting out behaviour, and socioeconomic factors. The limitations to generalisability are discussed.Trial registrationAustralian New Zealand Clinical Trials Registry ACTRN12610000332022 |
| Keywords: | |
| 本文献已被 SpringerLink 等数据库收录！ | |